| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
64,521,154 |
shares |
0.38% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.008 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$17,269,000,000 |
USD |
6.6% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$126,000,000 |
USD |
14% |
Q4 2025 |
FY 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,173,000,000 |
USD |
17% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability |
$672,000,000 |
USD |
11% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$5,489,000,000 |
USD |
-5.8% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$792,000,000 |
USD |
9.7% |
Q4 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$2,450,000,000 |
USD |
10% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$115,000,000 |
USD |
-5.7% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$123,000,000 |
USD |
24% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$137,000,000 |
USD |
-3.5% |
Q4 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.038 |
pure |
-2.6% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$120,000,000 |
USD |
2.6% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$97,000,000 |
USD |
21% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$250,000,000 |
USD |
-3.8% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$70,000,000 |
USD |
17% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$8,356,000,000 |
USD |
8.4% |
Q4 2025 |
FY 2025 |
| Amortization of Intangible Assets |
$204,000,000 |
USD |
-7.7% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,047,000,000 |
USD |
17% |
Q4 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$613,000,000 |
USD |
2.3% |
Q4 2025 |
FY 2025 |